The Pharmaceutical Industry and International Clinical Research: One Company’s Approach Michael Clayman, M.D. Vice President, Lilly Research Laboratories.

Slides:

Advertisements

Similar presentations

Research Governance Where Does Ethical Review Fit?

Advertisements

Group 1.3 Relationships between RECs in multi-centre, international studies –problems and solutions.

Ethics review and oversight for better governance of health research Amar Jesani Indian Journal of Medical Ethics Centre for Studies in Ethics and Rights.

Large Research and Medical Databases in clinical and research multi-centre trials in Africa African Movement for Ethics and Bioethics JUNE 19TH, 2012 COPENHAGEN,

Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.

Medical Science Liaison Clinical Science Liaison BY: Jamar G.

ETHICS OF CONSENTING IMPAIRED INDIVIDUALS THERAPEUTICS Col Xolani Currie, Nat Dipl Rad, BA, HED, MPH Regulatory Oversight Manager Project Phidisa.

Adapted from ISEF webpage Society for Science and the Public “Roles and Responsibilities of students and adults” Roles and Responsibilities of students.

© 2004 Aeras Global TB Vaccine Foundation Introduction to Clinical Research Clinical Research Practice 1.

Ethical regulations for health research involving human subjects in Cambodia By Chap Seak Chhay, MD, MPH, MHPEd Public Health and Health Professions Educator.

Good Clinical Practice in Research

T esting and deployment of GM mosquitoes: what is different? Ethical Review Process Instituto Conmemorativo Gorgas Vicente Bayard.

GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.

Post-trial Access to Treatment by Patients participating in Clinical Trials Presented by Dr T K S Letlape Chairman: South African Medical Association President-Elect:

Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.

Justification of Research in Humans Impossible to reach the important conclusions without studying humans Impossible to reach the important conclusions.

STANDARD Anything serving as a type or pattern to which other like things must conform (Stedman’s Medical Dictionary) STANDARD OF CARE The level at which.

Ethics in research involving human subjects

Research Ethics John Porter London School of Hygiene and Tropical Medicine.

Good Clinical Practice GCP

Clinical Research Conference 2012 Legal, Ethical, and Social Dimensions of Clinical Research Takis Vidalis, Ph. D., Hellenic National Bioethics Commission.

Clinical Research Training

International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.

Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.

Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.

Summary About me & AMRC About the EU Clinical Trials Regulation – what’s new Implementation timeline What does this mean for UK ethicists?

Glenn Rivard, Department of Justice 02/XI/22 Research Involving Humans Federal Governance.

Clinical Research in South Africa - Ethical and Regulatory Processes NATIONAL HEALTH RESEARCH ETHICS COUNCIL Professor A Dhai Deputy Chair National Health.

What makes Clinical Research Ethical? Dr Enoka Corea Co-secretary, ERC Faculty of Medicine, Colombo.

1 How to Review a Protocol. 2 Reference Documents WHO/TDR Operational Guidelines for Ethical Committees that Review Biomedical Research, International.

Improving Access and Quality Use of Medicines in Palliative Care within National Drug Policy, Regulatory, and Funding Frameworks Debra Rowett, Tania Shelby-James,

Public Health Ethics and Leadership: Getting it Right! Leslie E. Wolf, J.D., M.P.H. Georgia State University College of Law Center for Law, Health & Society.

The Global Health Network Marijke Geldenhuys 19 September 2014 Adhering to the GCP Principles.. what does that even mean?

Legal & Ethical Issues. Objectives At the completion of this session the participant will be able to: ◦ Describe the ethical principles associated with.

Institutional Review Board (IRB) What is our Purpose and Role for Ethical Research.

Doing ethical disability research: minimising harm for participant and researcher Australasian Association of Bioethics and Health Law Conference 14 July.

What happens when the research is over? Researcher and funder perspectives J Whitworth Head of International Activities Wellcome Trust Global Forum on.

IPASA presentation to Portfolio Committee on Health 31 October 2014 Abeda Williams.

The ELSI Implications of Gene Therapy under the UNESCO Declaration -a Taiwan’s Perspective Panelist ： Lin, Jui-Chu & Wang, Triumph.

Agenda for Session Compliance in Clinical Research

AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)

Identifying current and potential ethical challenges and Dilemmas in HIV prevention Research Ethics in clinical research: challenges linked.

National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.

ETHICAL ISSUES AND INFORMED CONSENT Juan M. Lozano, MD, MSc Department of Paediatrics and Clinical Epidemiology Unit School of Medicine, Javeriana University.

Lilly Answers that Matter. Preserving the Value of Industry Interactions with Health Care Professionals Jack Harris, M.D. Vice President, U.S. Medical.

HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.

Chapter 5 Ethical Concerns in Research. Historical Perspective on Ethics Nazi Experimentation in WWII –“medical experiments” –Nuremberg War Crime Trials.

Pediatric Research Ethics and the Research Subject Advocate Tomas Jose Silber, MD, MASS RSA and Director, Office of Ethics, CNMC Professor of Pediatrics,

Ethical issues with the regulatory use of gene expression data Benjamin S Wilfond MD Medical Genetics Branch National Human Genome Research Institute Department.

21 CFR Toby A. Silverman, M.D. Branch Chief, Clinical Review Branch Division of Hematology, Office of Blood December 14, 2006.

Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.

Introduction to Research Governance, Ethics and Integrity Mrs April Lockyer Senior Research Policy Officer (Governance and Integrity)

1 AVAREF MEETING – 24 th, September, 2010 Nairobi - Kenya Registry component: Pilot Implementation Experience in Tanzania Fimbo,

Global Clinical Trials Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast,

GCP (GOOD CLINICAL PRACTISE)

Good Clinical Practice (GCP) and Monitoring Practices

The IFPMA Code and how to set up a national self-regulation system Presentation to China/EU Pharmaceutical Industry Forum 17 May 2017, Shanghai, China.

A capacity building programme for patient representatives

Ethics in Human Medical Research

The Importance of Ethical and Human Rights Issues in Global Health

ICH-GCP Avinash Kondawar M. Pharm Lead CRA

Principles of Veterinary Medical Ethics

How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.

Good Clinical Practice

Ethical Principles of Research

راهنماي اختصاصي اخلاق در كارآزمايي هاي باليني

AGREEMENT FOR TRANSPARENCY The Case of Mexico

Clinical Research Association TURKEY

‘Data ethics and bio-banking’

Presentation transcript:

The Pharmaceutical Industry and International Clinical Research: One Company’s Approach Michael Clayman, M.D. Vice President, Lilly Research Laboratories Eli Lilly and Company OIA Speaker Series May 5, 2006

OIA Speaker Series May 5, Background Lilly conducts corporate-sponsored clinical research in 17 countries Including India and China With the exception of South Africa, not in Africa Conduct of clinical trials in developing countries considered by Lilly Bioethics Committee (BEC) over several months BEC – R and D leaders (medical, regulatory, legal) + Bob Levine and Tom Beauchamp Consultation with Eric Meslin

OIA Speaker Series May 5, Conduct of International Clinical Trials: BEC Position Statement Lilly applies a single baseline global standard to the conduct of clinical trials. Specifically, Lilly conducts all trials in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Clinical Practices and applicable laws and regulations of the country or countries where the study is being conducted.

OIA Speaker Series May 5, Conduct of International Clinical Trials: BEC Position Statement Lilly is a global company serving the medical needs of a global population. In choosing locations throughout the world to conduct clinical trials, Lilly is guided by the local prevalence of the burden of disease under study and the medical research capabilities of the candidate institutions.

OIA Speaker Series May 5, Conduct of International Clinical Trials: BEC Position Statement In addition, Lilly works in consultation with local ethics committees and/or health authorities, as appropriate, to ensure that conducting the proposed research in each location is scientifically and ethically justified, taking into consideration the following: the risks and benefits for research participants, the potential for the research to yield important scientific advances, the relevance of the research to local health needs and priorities, and the availability of the intervention under study to research participants and/or the community.

OIA Speaker Series May 5, Conduct of International Clinical Trials: BEC Position Statement In applying these considerations, Lilly places paramount importance on the safety and well-being of the individual research participants.